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DOI: 10.1002/pd.5522CORR E S PONDENC EIs it feasible to select fetuses for prenatal WES based on the
prenatal phenotype?Recently published studies have shown the feasibility of whole exome
sequencing (WES) in prenatal diagnosis.1,2 As WES is not yet routinely
implemented in all cases of fetal anomalies, discussions arise on which
fetuses should be referred for broad genetic testing. The diagnostic yield
is highest in fetal cases with multiple congenital anomalies. Therefore,
recently Lord and et al1 suggested that WES is best performed by
targeting those groups, inwhich it ismost likely to be diagnostic, allowing
a high diagnostic yield. We do agree that these cases have a clear indica-
tion for WES, which will lead to a diagnosis in 15.4%, as shown by Lord
et al (2019). This is important knowledge for the parents and relevant
information for assessment of the recurrence risk. However, in many of
such cases, a prenatal genetic diagnosis does not add significantly to
decisions on pregnancy management. Eg, in case of a fetus with short
extremities, a narrow thorax and polydactyly, the molecular diagnosis
Ellis Van Creveld syndrome does neither change the fetal prognosis,
nor perinatal management of the pregnancy. This is also supported
by the paper of Lord et al, since 20/52 (38.5%) diagnoses were made
in pregnancies that were terminated based solely on the ultrasound
abnormalities. We think that the detection of genetic variants as a
syndromic cause of fetal anomalies may be especially valuable in pre-
natal cases with a less severe phenotype or cases with an apparently
isolated anomaly, in which a molecular diagnosis has a larger impact
on decision‐making during pregnancy or neonatal management. In
such cases, parents are facing difficult decisions based on an incom-
plete phenotype. It is well known that many syndromes have postna-
tal features that cannot be detected prenatally on routine or expert
ultrasound scans, eg, intellectual disability or hypotonia. An example
is the case of Lord et al with an atrioventricular canal defect, where
a pathogenic variant in the ANKRD11 gene was detected (KBG syn-
drome). An intellectual disability in addition to a structural cardiac
defect can significantly influence the prospective parents' decision
on continuing or terminating the pregnancy. Petrovski et al 2 found
a variant in the L1CAM gene in a male fetus with agenesis of the cor-
pus callosum. In our practice, we have diagnosed several severe
syndromic disorders in fetuses presenting with milder or isolated
anomalies, eg, Cornelia de Lange syndrome (NIPBL) in a fetus with- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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Breakage syndrome (DDX11) in a fetus with apparently isolated intra
uterine growth restriction on a second trimester fetal anomaly scan.
Therefore, based on such examples from the literature as well as
from our clinical practice, we question whether is it feasible to select
fetuses with a high risk for a syndromic disorder based on the sever-
ity of the prenatal phenotype and we suggest to offer WES in all
cases with fetal anomalies.
We propose to offer prenatal “top‐priority” WES to pregnant cou-
ples (regardless of the severity of the fetal anomalies) who are in
doubt about decisions on the course of their pregnancy and/or prob-
ably would only consider termination of pregnancy when a severe
underlying genetic condition is identified. “Priority” WES should be
offered to prospective parents who continue the pregnancy regardless
of the genetic anomaly, but in which cases, a diagnosis can potentially
influence perinatal/neonatal management. And finally, “routine/post-
partum” WES could be offered in all cases with fetal anomalies who
decide to terminate the pregnancy, in which a genetic diagnosis is
mainly valuable to assess the recurrence risk and the diagnostic proto-
col in future pregnancies.
As advised by the guidelines of the ISPD 2018,3 we still offer
WES in selected prenatal cases in the setting of a multidisciplinary
team. However, we anticipate that, similar to microarray, prenatal
WES soon will be routinely offered in all cases with ultrasound
anomalies that undergo invasive sampling. Pretest and especially
posttest counseling are of vital importance as it should be noted that
where a normal result of WES in case of a “mild” prenatal phenotype
is reassuring for prospective parents, one can never exclude the
presence of an underlying syndrome. After all, not all pathogenic var-
iants can be detected by WES and some of the variants cannot be
classified as (likely) pathogenic in the absence of the postnatal
phenotype.
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